Project Profile

Protocol ISIS 183750-CS3 A Phase 1b-2 Study of Docetaxel and Prednisone, with or without ISIS 183750 (an eIF4E Inhibitor), in Patients with Castrate-Resistant Prostate Cancer.

Keyword Search